Create issue ticket

173 Possible Causes for Noncompliance, Obesity, Phosphate Decreased

  • Chronic Alcoholism

    Changes in PTEN expression and/or activity have been identified in a variety of chronic hepatocellular disorders including obesity, NAFLD, NASH, and alcoholism.[] Clients must occasionally be discharged as noncompliant, which reinforces to the chronic relapser that he/she can no longer successfully live on self will.[] Furthermore, calories from alcohol consumption lead to obesity, which adds even more risk for heart problems.[]

  • Asthma

    […] serum levels of potassium, magnesium, and phosphate.[] A wealth of epidemiologic literature has established that whereas asthma can lead to obesity, obesity is a risk factor for asthma, but mechanisms are unclear.[] A meta-analysis by DiMatteo et al [ 50 ] revealed that patients with a chronic disease and depression were three times more likely to be noncompliant with medical treatment[]

  • Gout

    Over 80 % are pure uric acid stones, the rest are mixed calcium oxalate stones or calcium phosphate stones.[] BACKGROUND: Hyperuricemia and gout represent important issues in the obese patients.[] A 43-year-old man previously diagnosed as having gout, and noncompliant with treatment, presented with tophaceous gout associated with discharging sinus and infection on his[]

  • Schizophrenia

    Nicotinamide adenine dinucleotide phosphate-diaphorase neurons were reduced in superficial WM and showed variable densities in deeper WM.[] Conference participants reviewed the literature in the following areas: 1) weight gain and obesity; 2) diabetes; 3) hyperlipidemia; 4) prolongation of the QT interval on the[] Long-term use can develop dependence and put the patient at risk if they are noncompliant.[]

  • Adrenocortical Carcinoma

    […] who was admitted to our hospital due to hypertension, severe hypokalaemia and metabolic alkalosis; physical examination was remarkable for plethoric moon face, centripetal obesity[] Reasons for treatment discontinuation were disease progression ( n  32 [64.0%]), AE ( n  5 [10.0%]), death ( n  3 [6.0%]), withdrawal of consent ( n  2 [4.0%]), protocol noncompliance[] He reported no chest symptom and did not exhibit any established risk factors for coronary artery disease, such as diabetes, obesity, hypertension or relevant family history[]

  • Portal Cirrhosis

    Unfortunately, physical exam will not be accurate in an extremely obese patient.[] Dietary restrictions and prohibition of alcohol may result in noncompliance in some patients.[] If you are overweight or obese, talk to your doctor about how to safely lose weight.[]

  • Diabetic Ketoacidosis

    Phosphate concentration decreases with insulin therapy.[] Abstract Proprotein convertase 1/3 (PC1/3) deficiency is a very rare disease characterized by severe intractable diarrhea in the first years of life, followed by obesity and[] The most common precipitating factor is infection, followed by noncompliance with insulin therapy. 3 While insulin pump therapy has been implicated as a risk factor for DKA[]

  • Essential Hypertension

    It was observed that the methylation levels of all of the eight CpG dinucleotides were decreased in the EH group compared with the control group; however, only CpG1 (2.83[] Abdominal obesity is a risk factor for cardiovascular disease worldwide, and it is becoming a dramatic issue for national health systems.[] Patients who continue to be noncompliant will often return to the emergency room within weeks.[]

  • Hyperuricemia

    Results Sevelamer significantly decreased serum phosphate value three and six months after administration.[] BACKGROUND: Hyperuricemia and gout represent important issues in the obese patients.[] Our observations show that self-induced vomiting to prevent effective treatment may be a disease-specific pattern of noncompliance with drug therapy in anorexia nervosa.[]

  • Vitamin D Deficiency

    […] and inorganic phosphate concentrations, secondary hyperparathyroidism and decreased serum 25-hydroxyvitamin D (25(OH)D) levels.[] Trial, Obesity, 26, 4, (651-657), (2018).[] Two studies made specific reference to dropouts and sought to give some clarification about the reasons for dropout or noncompliance ( 15, 16 ), whereas 3 studies recorded[]

Similar symptoms